President-Elect Trump’s Health Policy Agenda: Priorities, Strategies, and Predictions
The Petrie-Flom Center hosted a live web panel to address what health care reform might look like under President-elect Trump's administration. Expert panelists discussed the future of the Affordable Care Act under a "repeal and replace" strategy, alternative approaches to insurance coverage and access to care, the problem of high drug prices, innovation policy, support for scientific research, and other topics. The panel also discussed opportunities and obstacles relevant to President-elect Trump’s proposals, as well as hopes and concerns for health policy the Trump administration.
Panelists
-
Joseph R. Antos, Wilson H. Taylor Scholar in Health Care and Retirement Policy, American Enterprise Institute
-
Lanhee J. Chen, David and Diane Steffy Research Fellow, Hoover Institution; Director of Domestic Policy Studies and Lecturer, Public Policy Program; affiliate, Freeman Spogli Institute for International Studies, Stanford University
-
Douglas Holtz-Eakin, President, American Action Forum
-
Moderator: Gregory Curfman, Editor-in-Chief, Harvard Health Publications
This web panel was free and open to the public.
Learn More
-
Check out the discussion on Twitter @PetrieFlom!
-
Watch the Petrie-Flom Center's pre-election panel discussion, held in October 2016, "Health Care after the Election."
-
Listen to Joseph R. Antos on "The future of the Affordable Care Act and plans to repeal" (American Enterprise Institute interview with Patricia Salber, December 14, 2016)
-
Read Tevi Troy and Lanhee Chen on how "The GOP's Obamacare Strategy Pays Off" (Wall Street Journal, November 13, 2016)
-
Read Douglas Holtz-Eakin and Patrick Hefflinger on "Repealing and Replacing Obamacare" (American Action Forum Daily Dish, December 15, 2016)
Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Harvard Law School Association.
Videos
VIDEO: Introduction, Gregory Curfman
Tags
fda health care finance health care reform health law policy innovation insurance pharmaceuticals public health regulation research funding